NASDAQ:PIII P3 Health Partners (PIII) Stock Price, News & Analysis $8.91 +0.26 (+3.01%) Closing price 03:59 PM EasternExtended Trading$8.78 -0.13 (-1.40%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About P3 Health Partners Stock (NASDAQ:PIII) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get P3 Health Partners alerts:Sign Up Key Stats Today's Range$8.58▼$9.0850-Day Range$5.80▼$10.1952-Week Range$5.80▼$26.00Volume7,700 shsAverage Volume22,156 shsMarket Capitalization$64.04 millionP/E RatioN/ADividend YieldN/APrice Target$16.25Consensus RatingHold Company Overview P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements. The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics. By combining proprietary software with professional services teams, P3 Health Partners assists payers in identifying gaps in care, enhancing member engagement and ensuring compliance with state and federal guidelines. Its solutions encompass data ingestion, normalization, predictive modeling and targeted outreach strategies designed to drive measurable improvements in clinical and financial outcomes. Headquartered in Dallas, Texas, P3 Health Partners serves a broad base of commercial, Medicare Advantage and Medicaid health plans across the United States. The company is led by a management team with deep expertise in healthcare analytics, payer operations and quality improvement initiatives. Through strategic partnerships and ongoing investment in its technology platform, P3 Health Partners aims to help clients navigate the evolving healthcare landscape and deliver more cost-effective, member-centric care.AI Generated. May Contain Errors. Read More P3 Health Partners Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks51st Percentile Overall ScorePIII MarketRank™: P3 Health Partners scored higher than 51% of companies evaluated by MarketBeat, and ranked 556th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.4 / 5Analyst RatingHold Consensus RatingP3 Health Partners has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.Upside PotentialP3 Health Partners has a consensus price target of $16.25, representing about 82.4% upside from its current price of $8.91.Amount of Analyst CoverageP3 Health Partners has only been the subject of 2 research reports in the past 90 days.Read more about P3 Health Partners' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for P3 Health Partners are expected to grow in the coming year, from ($0.67) to ($0.37) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of P3 Health Partners is -0.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of P3 Health Partners is -0.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioP3 Health Partners has a P/B Ratio of 0.84. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about P3 Health Partners' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.30% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 4.78%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldP3 Health Partners does not currently pay a dividend.Dividend GrowthP3 Health Partners does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.30% of the float of P3 Health Partners has been sold short.Short Interest Ratio / Days to CoverP3 Health Partners has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in P3 Health Partners has recently decreased by 4.78%, indicating that investor sentiment is improving. News and Social Media1.1 / 5News SentimentN/A Search Interest4 people have searched for PIII on MarketBeat in the last 30 days. MarketBeat Follows1 people have added P3 Health Partners to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, P3 Health Partners insiders have not sold or bought any company stock.Percentage Held by Insiders17.79% of the stock of P3 Health Partners is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 7.75% of the stock of P3 Health Partners is held by institutions.Read more about P3 Health Partners' insider trading history. Receive PIII Stock News and Ratings via Email Sign-up to receive the latest news and ratings for P3 Health Partners and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PIII Stock News HeadlinesP3 Health Partners to Participate in the Jefferies Healthcare Services ConferenceSeptember 17, 2025 | businesswire.comP3 Health Partners Earnings Call: Challenges and ProgressSeptember 8, 2025 | theglobeandmail.comAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.October 6 at 2:00 AM | Porter & Company (Ad)Catalyst Solutions Announces Successful Launch of P3 Implementation Across Four StatesAugust 25, 2025 | prnewswire.comP3 Health Partners Inc. (PIII) Q2 2025 Earnings Call TranscriptAugust 14, 2025 | seekingalpha.comP3 Health Partners Announces Second Quarter 2025 ResultsAugust 14, 2025 | businesswire.comP3 Health Partners Schedules Second Quarter 2025 Earnings Release and Conference CallJuly 31, 2025 | businesswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.July 28, 2025 | globenewswire.comSee More Headlines PIII Stock Analysis - Frequently Asked Questions How have PIII shares performed this year? P3 Health Partners' stock was trading at $11.2450 at the start of the year. Since then, PIII stock has decreased by 20.8% and is now trading at $8.91. How were P3 Health Partners' earnings last quarter? P3 Health Partners Inc. (NASDAQ:PIII) released its quarterly earnings results on Thursday, August, 14th. The company reported ($6.23) earnings per share for the quarter, missing analysts' consensus estimates of ($3.29) by $2.94. The firm earned $355.79 million during the quarter, compared to analysts' expectations of $356.52 million. P3 Health Partners had a negative net margin of 9.99% and a negative trailing twelve-month return on equity of 183.60%. Read the conference call transcript. When did P3 Health Partners' stock split? P3 Health Partners's stock reverse split on the morning of Monday, April 14th 2025.The 1-50 reverse split was announced on Friday, April 4th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 11th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of P3 Health Partners? Shares of PIII stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of P3 Health Partners own? Based on aggregate information from My MarketBeat watchlists, some other companies that P3 Health Partners investors own include Avino Silver & Gold Mines (ASM), PayPal (PYPL), TriNet Group (TNET), Taiwan Semiconductor Manufacturing (TSM), XPeng (XPEV), 3M (MMM) and nCino (NCNO). Company Calendar Last Earnings8/14/2025Today10/06/2025Next Earnings (Estimated)11/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MEDICAL INFO SYS Sub-IndustryHealthcare Current SymbolNASDAQ:PIII CIK1832511 Webforesightacq.com Phone702-910-3950FaxN/AEmployees500Year FoundedN/APrice Target and Rating Average Price Target for P3 Health Partners$16.25 High Price Target$20.00 Low Price Target$12.50 Potential Upside/Downside+86.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($46.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$135.85 million Net Margins-9.99% Pretax Margin-21.58% Return on Equity-183.60% Return on Assets-17.83% Debt Debt-to-Equity Ratio2.29 Current Ratio0.31 Quick Ratio0.31 Sales & Book Value Annual Sales$1.46 billion Price / Sales0.04 Cash FlowN/A Price / Cash FlowN/A Book Value$10.58 per share Price / Book0.82Miscellaneous Outstanding Shares7,187,000Free Float5,908,000Market Cap$62.61 million OptionableNot Optionable Beta0.84 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:PIII) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.